Lunit (328130.KQ) Stock Price

Lunit Price

CLOSED
14,040.00
​
Market closed

Over the last 5 years Lunit grew revenue by 144.9% annually, reaching 17.46 B KRW. For Lunit, the net margin of 2.9% is up versus -5,855.7% a few years ago. The consensus 12-month price target for Lunit is 28,652.74 KRW, about 104.1% above where the stock trades today. Of 6 analysts, 0 rate the stock a buy — an overall Sell consensus.

Lunit stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lunit business model & stock analysis

Lunit Inc is a South Korean company headquartered in Seoul, operating within the Health Care sector. The company has 293 employees and went public on July 21, 2022, with its ticker listed as 328130.KQ and ISIN KR7328130000. Lunit provides software solutions for medical diagnostic imaging services, focusing on the development and supply of AI-powered medical software. Its offerings include cancer diagnostic aid solutions, cancer early detection solutions, and cancer risk prediction solutions. The company's technology leverages artificial intelligence to enhance diagnostic capabilities in healthcare settings. Lunit's website is www.lunit.io, where further information about its services and solutions can be accessed. The company operates in the Health Care industry, specifically targeting medical imaging and AI-driven diagnostic tools. As of the latest available data, Lunit is engaged in the development and commercialization of AI-based medical software, aiming to improve the accuracy and efficiency of cancer-related diagnostics. The firm's IPO date marks its transition to a publicly traded company, reflecting its growth and market position in the healthcare technology space. Lunit's focus on AI applications in medical imaging positions it as a key player in the digital health sector, particularly within the Korean market and beyond. The company's solutions are designed to support healthcare professionals in making more informed diagnostic decisions, potentially reducing the time and resources required for cancer detection and treatment planning.

Frequently asked questions about Lunit

Analysts currently set an average price target of 28,652.74 KRW for the Lunit stock (median: 28,652.74 KRW), implying +104.1 % versus the latest price. The consensus is based on 6 analyst ratings.

6 analysts currently rate the Lunit stock: 0 recommend buying, 2 holding and 4 selling. For 2026, analysts expect Lunit to generate revenue of 89.23 B KRW and earnings per share of -1,372.30 KRW.

Converted at the current exchange rate, the Lunit share trades at 9.32 EUR (14,040.00 KRW).

The expected revenue of Lunit is 89.23 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Lunit is -570.29 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Lunit is currently -10.23. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Lunit stock.

The price-to-sales ratio (P/S) of Lunit is currently 65.39. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Lunit stock.

The Eulerpool Quality Score for Lunit is 4/10.

The ISIN of Lunit is KR7328130000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Lunit is 328130.KQ. The ticker symbol is used to trade Lunit shares on the stock exchange.

Fair ValueTerminal
14,742.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
59.60 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website lunit.io
Country
South Korea
Currency
KRW
Initial public offering
Jul 21, 2022
ISIN
KR7328130000
Cusip
Y534BD100
Market capitalization
5.83 T KRWMega Cap
52-Week Range
PEG
428.36
P/E ratio
P/Ee 2025
-46.12
P/Ee 2026
-10.23
P/Ee 2027
-14.28
P/Ee 2028
-17.55
P/Se
74.04
EV/EBIT
10,711.98
P/B Ratio
902.14
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.50 %
Last updated Nov 5, 2026, 1:21 PM

Lunit Peer Group

Lunit FIGI

328130:KS · BBG00M0PDPG8328130:KQ · BBG0186L86S6

All fundamentals and in-depth analysis of Lunit

Our stock analysis for Lunit stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lunit. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.